Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
30 participants
INTERVENTIONAL
2010-01-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
exercise
Multimodal exercises that include walking, breathing exercises, dynamic balance, and core strengthening.
Exercise
3 month exercise intervention, three days a week Progressive in duration - up to 1 hour daily; Progressive in intensity
Multi-modal exercise program includes a) aerobic - walking, b) resistive training with therabands and core exercises, and c) breathing exercises
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
3 month exercise intervention, three days a week Progressive in duration - up to 1 hour daily; Progressive in intensity
Multi-modal exercise program includes a) aerobic - walking, b) resistive training with therabands and core exercises, and c) breathing exercises
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* adults age 18-70
Exclusion Criteria
* unstable angina
* recent (\<3 month) myocardial infarction, stroke, hospitalization for major illness or major surgery
* chronic pain or orthopedic condition restricting exercise
* active cancer, excluding basal cell cancer
* anemia (HCT \<30)
* pregnancy
* myasthenia gravis exacerbation in past 3 months
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Maryland
OTHER
Baltimore VA Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Charlene Elaine Hafer-Macko
Myasthenia Gravis and Exercise
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charlene E Hafer-Macko, MD
Role: PRINCIPAL_INVESTIGATOR
Baltimore VA Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Maryland and Baltimore VA Medical Center
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
Myasthenia Gravis Foundation of America
University of Maryland Myasthenia Gravis Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Myasthenia and Exercise
Identifier Type: -
Identifier Source: org_study_id